Company intelligence / Profile preview

Cibus Health

San Diego, California, USAige.ucsd.edu ↗

Ownership: Private
Development stage: Other

Overview

Cibus has developed and commercialized several gene-edited plant traits through licensing partnerships with major seed companies. Its technology enables rapid development of disease-resistant and high-yield crops without introducing foreign DNA. The company has achieved milestones such as developing white mold-resistant canola and advancing soybean platforms. Initial bioassay data show promising results for new disease-resistance modes of action.

Therapeutic areas: Other
Modalities: Gene editing
Industry: Agriculture & AgTech

Partnerships

Major seed companies via licensing agreements

Beyond the preview

Go deeper on Cibus Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cibus Health.

Explore the full profile